Methodology and clinical utility of longitudinal <scp><i>UBA1</i></scp> tracking in <scp>VEXAS</scp> syndrome
2024 · British Journal of Haematology · 10 citations
https://doi.org/10.1111/bjh.19897
G
Giulia Rivoli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
376
Citations
8
h-index
8
i10-index
Giulia Rivoli is an academic researcher from Ospedale Policlinico San Martino. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Cutaneous lymphoproliferative disorders research & CAR-T cell therapy research. The author has an h-index of 8, co-authored 40 publications.
ORCID: 0009-0003-8709-2525Papers by this author
worksDurable outcomes with manageable safety leading to prolonged survival with tagraxofusp for treatment-naïve patients with blastic plasmacytoid dendritic cell neoplasm: real world results from a European Named Patient Program
2025 · Annals of Hematology · 3 citations
https://doi.org/10.1007/s00277-025-06493-w
SPECIFIC DISEASE ENTITIES - VEXAS/ VEXAS-LIKE DISEASE
2025 · Leukemia Research · 0 citations
https://doi.org/10.1016/j.leukres.2025.107898
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat